- Home
- ACNT vs GNLX Comparison
ACNT vs GNLX Comparison
Compare ACNT & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACNT
- GNLX
- Stock Information
- Founded
- ACNT 1945
- GNLX 2001
- Country
- ACNT United States
- GNLX United States
- Employees
- ACNT N/A
- GNLX N/A
- Industry
- ACNT Steel/Iron Ore
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- ACNT Industrials
- GNLX Health Care
- Exchange
- ACNT Nasdaq
- GNLX Nasdaq
- Market Cap
- ACNT 122.5M
- GNLX 129.9M
- IPO Year
- ACNT N/A
- GNLX 2023
- Fundamental
- Price
- ACNT $12.96
- GNLX $3.34
- Analyst Decision
- ACNT
- GNLX Strong Buy
- Analyst Count
- ACNT 0
- GNLX 5
- Target Price
- ACNT N/A
- GNLX $16.20
- AVG Volume (30 Days)
- ACNT 96.0K
- GNLX 151.6K
- Earning Date
- ACNT 08-05-2025
- GNLX 08-13-2025
- Dividend Yield
- ACNT N/A
- GNLX N/A
- EPS Growth
- ACNT N/A
- GNLX N/A
- EPS
- ACNT N/A
- GNLX N/A
- Revenue
- ACNT $174,652,000.00
- GNLX N/A
- Revenue This Year
- ACNT $22.72
- GNLX N/A
- Revenue Next Year
- ACNT N/A
- GNLX N/A
- P/E Ratio
- ACNT N/A
- GNLX N/A
- Revenue Growth
- ACNT 5.04
- GNLX N/A
- 52 Week Low
- ACNT $8.16
- GNLX $1.60
- 52 Week High
- ACNT $13.70
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- ACNT 54.08
- GNLX 54.17
- Support Level
- ACNT $12.70
- GNLX $3.23
- Resistance Level
- ACNT $13.16
- GNLX $3.70
- Average True Range (ATR)
- ACNT 0.22
- GNLX 0.28
- MACD
- ACNT 0.02
- GNLX 0.00
- Stochastic Oscillator
- ACNT 62.26
- GNLX 54.31
About ACNT Ascent Industries Co.
Ascent Industries Co is engaged in the chemical and metal industry. The group operates into two reportable segments namely the Specialty Chemicals and Tubular Products. The Tubular Products segment serves markets through pipe and tube and customers in the appliance, architectural, automotive, and commercial transportation, brewery, chemical, petrochemical, and other industries. The Specialty Chemicals segment produces specialty products for pulp and paper, coatings, adhesives, sealants, and elastomers (CASE), textile, automotive, household, and other industries. It manufactures welded pipe and tube, majorly from stainless steel, duplex, and nickel alloys. The company also produces specialty chemicals and dyes used in various end markets.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.